164 related articles for article (PubMed ID: 17158540)
1. Systemic chemotherapy for advanced bladder cancer: update and controversies.
Garcia JA; Dreicer R
J Clin Oncol; 2006 Dec; 24(35):5545-51. PubMed ID: 17158540
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy for bladder cancer.
Sonpavde G; Lerner SP
Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies.
Garcia JA; Dreicer R
Nat Clin Pract Urol; 2005 Jan; 2(1):32-7. PubMed ID: 16474574
[TBL] [Abstract][Full Text] [Related]
7. Update on chemotherapy for advanced bladder cancer.
Rosenberg JE; Carroll PR; Small EJ
J Urol; 2005 Jul; 174(1):14-20. PubMed ID: 15947569
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer.
Wosnitzer MS; Hruby GW; Murphy AM; Barlow LJ; Cordon-Cardo C; Mansukhani M; Petrylak DP; Benson MC; McKiernan JM
Cancer; 2012 Jan; 118(2):358-64. PubMed ID: 21717438
[TBL] [Abstract][Full Text] [Related]
9. Systemic chemotherapy in regionally advanced bladder cancer. Theoretical considerations and results.
Scher HI
Urol Clin North Am; 1992 Nov; 19(4):747-59. PubMed ID: 1441029
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel in the treatment of advanced urothelial cancer.
Bajorin DF
Oncology (Williston Park); 2000 Jan; 14(1):43-52, 57; discussion 58, 61-2. PubMed ID: 10680149
[TBL] [Abstract][Full Text] [Related]
11. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
[TBL] [Abstract][Full Text] [Related]
12. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.
Pectasides D; Pectasides M; Economopoulos T
Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
14. The evolving role of chemotherapy in advanced urothelial cancer.
Calabrò F; Sternberg CN
Curr Opin Support Palliat Care; 2007 Oct; 1(3):180-6. PubMed ID: 18685360
[TBL] [Abstract][Full Text] [Related]
15. [Concurrent radio-chemotherapy in infiltrating cancer of the bladder: a new therapeutic approach?].
Housset M; Dufour B; Durdux C; Chrétien Y; Méjean A; Baillet F
Cancer Radiother; 1998 Apr; 2 Suppl 1():67s-72s. PubMed ID: 9749082
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.
Shimabukuro T; Nakamura K; Uchiyama K; Tei Y; Aoki A; Naito K
Hinyokika Kiyo; 2006 Feb; 52(2):99-105. PubMed ID: 16541762
[TBL] [Abstract][Full Text] [Related]
18. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
Pollera CF; Nelli F
Expert Rev Anticancer Ther; 2006 Jan; 6(1):83-92. PubMed ID: 16375647
[TBL] [Abstract][Full Text] [Related]
19. [Is neoadjuvant chemotherapy valid in invasive cancer of the bladder?].
Matveev BP; Figurin KM
Urol Nefrol (Mosk); 1998; (6):42-5. PubMed ID: 10051828
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy in the treatment of advanced urothelial tumors].
Sternberg CN
Urologe A; 1991 Jan; 30(1):33-44. PubMed ID: 2014585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
